Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Pathway CH S&E Registry (SER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02440776
Recruitment Status : Unknown
Verified June 2018 by Autonomic Technologies, Inc..
Recruitment status was:  Active, not recruiting
First Posted : May 12, 2015
Last Update Posted : June 26, 2018
Information provided by (Responsible Party):
Autonomic Technologies, Inc.

Brief Summary:
Monitor the safety and performance of the Pulsante Microstimulator System.

Condition or disease
Cluster Headache

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: Pathway CH S&E Registry: Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache - ATI Neurostimulation System is Branded Internationally as Pulsante™ Microstimulator System
Study Start Date : April 2015
Actual Primary Completion Date : May 13, 2018
Estimated Study Completion Date : June 30, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Headache

Primary Outcome Measures :
  1. Characterization of all device/procedure related Adverse Events [ Time Frame: Through five years post implant ]
    Outcome will be assessed at Implant, 3, 6, 9, 12, 18, 24, 36, 48 and 60 months post implant.

Secondary Outcome Measures :
  1. Acute response to therapy [ Time Frame: Through five years post implant ]
    Outcome will be assessed at 3, 6, 9, 12, 18, 24, 36, 48 and 60 months post implant.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects who meet the CE marked labeling for cluster headache for the Pulsante Microstimulator System

Inclusion Criteria:

  1. Patient meets CE marked labeling for cluster headache.
  2. Patient has the ability to read, comprehend and reliably record information as required by the Protocol.
  3. Patient is able to provide written informed consent prior to participation in the study.

Exclusion Criteria:

1. Patient has other significant pain problem that might confound the study assessments in the opinion of the Investigator.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02440776

Layout table for location information
Rigshospitalet Neurocenter
Glostrup, Denmark, 2600
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Klinik und Poliklinik für Neurologie
Dresden, Germany, 01307
Düsseldorf, Germany, D-40225
Universitätsklinikum Freiburg
Freiburg, Germany, 79106
Klinik für Schmerztherapie, Rotes Kreuz Krankenhaus, Hansteinstr. 29
Kassel, Germany, 34121
Neurologie + Kopfschmerzzentrum Münchner Freiheit
Munich, Germany, 80802
Neurologiska Kliniken-Karolinska UniversitetssjukhusetSolna
Stockholm, Sweden, 17176
University Hospital Zurich, Klinik f. Neurologie, Frauenklinikstr. 26
Zurich, Switzerland, 8091
United Kingdom
The Walton Center
Liverpool, United Kingdom, L97LJ
Sponsors and Collaborators
Autonomic Technologies, Inc.
Additional Information:

Layout table for additonal information
Responsible Party: Autonomic Technologies, Inc. Identifier: NCT02440776    
Other Study ID Numbers: CP-010
First Posted: May 12, 2015    Key Record Dates
Last Update Posted: June 26, 2018
Last Verified: June 2018
Additional relevant MeSH terms:
Layout table for MeSH terms
Cluster Headache
Neurologic Manifestations
Trigeminal Autonomic Cephalalgias
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases